ID   ENH1_HUMAN              Reviewed;         584 AA.
AC   Q9N2K0; O00354; Q96L63; Q9UNM3;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-FEB-2021, entry version 96.
DE   RecName: Full=HERV-H_2q24.3 provirus ancestral Env polyprotein;
DE   AltName: Full=Env protein HERV-H/p62;
DE   AltName: Full=Env protein HERV-H19;
DE   AltName: Full=Env protein HERV-Hcl.3;
DE   AltName: Full=Envelope polyprotein;
DE   AltName: Full=HERV-H/env62;
DE   Contains:
DE     RecName: Full=Surface protein;
DE              Short=SU;
DE   Contains:
DE     RecName: Full=Transmembrane protein;
DE              Short=TM;
DE   Flags: Precursor;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-81 AND LEU-150.
RX   PubMed=10366582; DOI=10.1006/viro.1999.9750;
RA   Lindeskog M., Mager D.L., Blomberg J.;
RT   "Isolation of a human endogenous retroviral HERV-H element with an open env
RT   reading frame.";
RL   Virology 258:441-450(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-81 AND LEU-150.
RX   PubMed=11162811; DOI=10.1006/viro.2000.0737;
RA   de Parseval N., Casella J.-F., Gressin L., Heidmann T.;
RT   "Characterization of the three HERV-H proviruses with an open envelope
RT   reading frame encompassing the immunosuppressive domain and evolutionary
RT   history in primates.";
RL   Virology 279:558-569(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-402, AND VARIANT LEU-81.
RX   PubMed=12079564; DOI=10.1089/088922202760019383;
RA   Jern P., Lindeskog M., Karlsson D., Blomberg J.;
RT   "Full-length HERV-H elements with env SU open reading frames in the human
RT   genome.";
RL   AIDS Res. Hum. Retroviruses 18:671-676(2002).
RN   [4]
RP   FUNCTION.
RX   PubMed=11562544; DOI=10.1099/0022-1317-82-10-2515;
RA   Mangeney M., de Parseval N., Thomas G., Heidmann T.;
RT   "The full-length envelope of an HERV-H human endogenous retrovirus has
RT   immunosuppressive properties.";
RL   J. Gen. Virol. 82:2515-2518(2001).
RN   [5]
RP   FUNCTION.
RX   PubMed=14557543; DOI=10.1073/pnas.2132646100;
RA   Blaise S., de Parseval N., Benit L., Heidmann T.;
RT   "Genomewide screening for fusogenic human endogenous retrovirus envelopes
RT   identifies syncytin 2, a gene conserved on primate evolution.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:13013-13018(2003).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=12970426; DOI=10.1128/jvi.77.19.10414-10422.2003;
RA   de Parseval N., Lazar V., Casella J.-F., Benit L., Heidmann T.;
RT   "Survey of human genes of retroviral origin: identification and
RT   transcriptome of the genes with coding capacity for complete envelope
RT   proteins.";
RL   J. Virol. 77:10414-10422(2003).
CC   -!- FUNCTION: Retroviral envelope proteins mediate receptor recognition and
CC       membrane fusion during early infection. Endogenous envelope proteins
CC       may have kept, lost or modified their original function during
CC       evolution. This endogenous envelope protein has lost its original
CC       fusogenic properties but has immunosuppressive properties in vivo.
CC       {ECO:0000269|PubMed:11562544, ECO:0000269|PubMed:14557543}.
CC   -!- FUNCTION: SU mediates receptor recognition. {ECO:0000250}.
CC   -!- FUNCTION: TM anchors the envelope heterodimer to the viral membrane
CC       through one transmembrane domain. The other hydrophobic domain, called
CC       fusion peptide, mediates fusion of the viral membrane with the target
CC       cell membrane (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: The surface (SU) and transmembrane (TM) proteins form a
CC       heterodimer. SU and TM are attached by noncovalent interactions or by a
CC       labile interchain disulfide bond (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Virion.
CC   -!- SUBCELLULAR LOCATION: [Transmembrane protein]: Cell membrane
CC       {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Low expression in skin and testis. No expression in
CC       several cell lines. {ECO:0000269|PubMed:12970426}.
CC   -!- DOMAIN: Contains the CKS-17 immunosuppressive domain present in many
CC       retroviral envelope proteins. As a synthetic peptide, it inhibits
CC       immune function in vitro and in vivo (By similarity). {ECO:0000250}.
CC   -!- PTM: Specific enzymatic cleavages in vivo yield the mature SU and TM
CC       proteins. {ECO:0000250}.
CC   -!- PTM: The CXXC motif is highly conserved across a broad range of
CC       retroviral envelope proteins. It is thought to participate in the
CC       formation of a labile disulfide bond possibly with the CX6CC motif
CC       present in the transmembrane protein. Isomerization of the intersubunit
CC       disulfide bond to an SU intrachain disulfide bond is thought to occur
CC       upon receptor recognition in order to allow membrane fusion (By
CC       similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: Envelope protein HERV-H19 and HERV-H/p62 are allelic
CC       variants of the same provirus.
CC   -!- MISCELLANEOUS: Ortholog in Pan troglodytes.
CC   -!- MISCELLANEOUS: HERV-H family subgenomic RNAs have been observed.
CC   -!- MISCELLANEOUS: This provirus is intergenic, the closest flanking genes
CC       being TAIP2 and GALNT3.
CC   -!- SIMILARITY: Belongs to the gamma type-C retroviral envelope protein
CC       family. HERV class-I H env subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF108843; AAD34324.1; -; Genomic_DNA.
DR   EMBL; U88902; AAC79121.1; -; Genomic_DNA.
DR   EMBL; AJ289709; CAB94192.1; -; Genomic_DNA.
DR   EMBL; AY050297; AAL11491.1; -; Genomic_DNA.
DR   PIR; B44282; B44282.
DR   SMR; Q9N2K0; -.
DR   GlyGen; Q9N2K0; 8 sites.
DR   BioMuta; -; -.
DR   PeptideAtlas; Q9N2K0; -.
DR   PRIDE; Q9N2K0; -.
DR   ProteomicsDB; 81855; -.
DR   neXtProt; NX_Q9N2K0; -.
DR   PhylomeDB; Q9N2K0; -.
DR   Pharos; Q9N2K0; Tdark.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; Q9N2K0; protein.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   InterPro; IPR018154; TLV/ENV_coat_polyprotein.
DR   PANTHER; PTHR10424; PTHR10424; 1.
DR   Pfam; PF00429; TLV_coat; 2.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cleavage on pair of basic residues; Disulfide bond; ERV;
KW   Glycoprotein; Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Transposable element; Viral envelope protein; Virion.
FT   SIGNAL          1..35
FT                   /evidence="ECO:0000255"
FT   CHAIN           36..584
FT                   /note="HERV-H_2q24.3 provirus ancestral Env polyprotein"
FT                   /id="PRO_0000008460"
FT   CHAIN           36..387
FT                   /note="Surface protein"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000008461"
FT   CHAIN           388..584
FT                   /note="Transmembrane protein"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000008462"
FT   TOPO_DOM        36..523
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        524..544
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        545..584
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          388..408
FT                   /note="Fusion peptide"
FT                   /evidence="ECO:0000250"
FT   MOTIF           64..67
FT                   /note="CXXC"
FT                   /evidence="ECO:0000250"
FT   MOTIF           454..470
FT                   /note="CKS-17"
FT                   /evidence="ECO:0000250"
FT   MOTIF           471..479
FT                   /note="CX6CC"
FT                   /evidence="ECO:0000250"
FT   SITE            387..388
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        47
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        199
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        283
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        352
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        370
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        483
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        471..478
FT                   /evidence="ECO:0000250"
FT   VARIANT         81
FT                   /note="V -> L (in allele HERV-H19)"
FT                   /evidence="ECO:0000269|PubMed:10366582,
FT                   ECO:0000269|PubMed:11162811, ECO:0000269|PubMed:12079564"
FT                   /id="VAR_017799"
FT   VARIANT         150
FT                   /note="F -> L (in allele HERV-H19)"
FT                   /evidence="ECO:0000269|PubMed:10366582,
FT                   ECO:0000269|PubMed:11162811"
FT                   /id="VAR_017800"
FT   CONFLICT        80
FT                   /note="A -> T (in Ref. 3; AAL11491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        98
FT                   /note="F -> C (in Ref. 3; AAL11491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        316
FT                   /note="T -> A (in Ref. 3; AAL11491)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        319
FT                   /note="S -> G (in Ref. 1; AAC79121)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   584 AA;  64318 MW;  C03D260B5A60BDAB CRC64;
     MIFAGKAPSN TSTLMKFYSL LLYSLLFSFP FLCHPLPLPS YLHHTINLTH SLLAASNPSL
     VNNCWLCISL SSSAYTAVPA VQTDWATSPI SLHLRTSFNS PHLYPPEELI YFLDRSSKTS
     PDISHQQAAA LLRTYLKNLS PYINSTPPIF GPLTTQTTIP VAAPLCISWQ RPTGIPLGNL
     SPSRCSFTLH LRSPTTNINE TIGAFQLHIT DKPSINTDKL KNISSNYCLG RHLPCISLHP
     WLSSPCSSDS PPRPSSCLLI PSPENNSERL LVDTRRFLIH HENRTFPSTQ LPHQSPLQPL
     TAAALAGSLG VWVQDTPFST PSHLFTLHLQ FCLAQGLFFL CGSSTYMCLP ANWTGTCTLV
     FLTPKIQFAN GTEELPVPLM TPTQQKRVIP LIPLMVGLGL SASTVALGTG IAGISTSVMT
     FRSLSNDFSA SITDISQTLS VLQAQVDSLA AVVLQNRRGL DLLTAEKGGL CIFLNEECCF
     YLNQSGLVYD NIKKLKDRAQ KLANQASNYA EPPWALSNWM SWVLPIVSPL IPIFLLLLFG
     PCIFRLVSQF IQNRIQAITN HSIRQMFLLT SPQYHPLPQD LPSA
//
